Have a Look at Hedge Funds' Recent Moves in These Three Stocks
There is no doubt that some hedge funds’ 13F filings disclose rich trading ideas, but these filings are generally considered delayed and irrelevant.
Hedge Fund - Point72 Asset Management
News, Interviews, and Investor Letters
- First
- << Previous
- 341 - 350
- Next >>
Want to Invest Like a Hedge Fund? Have a Look at These 3 Stocks Favored by Top Money Managers
Benjamin Graham divided investors into two types: defensive investors and enterprising investors.
Billionaire Steven Cohen’s New High Dividend Stock Picks
The 10-year U.S treasury bond yield went below the critical 2% mark recently, hitting a fresh 5-month low at 1.99%.
Orexigen Therapeutics Inc. (OREX) and Spectranetics Corp (SPNC): Billionaires Klarman and Cohen Snapped Up These Healthcare Stocks
Seth Klarman’s Baupost Group has initiated a new passive stake in Orexigen Therapeutics Inc. (NASDAQ:OREX), a new filing the U.S. Securities and Exchange Commission showed.
Hedge Fund Sentiment Has This To Say About Steven Cohen And Steven Boyd's Latest Moves
Hedge fund managers and other investors had identified investment opportunities prior to the broader market pullback in August, so why not acquire more shares on the cheap? Most hedge funds have been ...
Should Investors Follow Steve Cohen's Move On This Chemical Company?
Olin Corporation (NYSE:OLN) is still an attractive investment for Steven Cohen or so suggests his fund's latest filing with the Securities and Exchange Commission. Point72 Asset Management has disclosed...
George Soros And Steve Cohen: Two Tech Stocks They Like And One They Got Rid Of
In any discussions concerning legendary investors, George Soros and Steve Cohen are two names that are bound to come up. While Mr.
Steve Cohen Believes It's Time to Bet on Sunedison Inc (SUNE)
According to a new filing with the SEC, Steve Cohen's Point72 Asset Management has acquired some 13.74 million shares of Sunedison Inc (NYSE:SUNE), to take the firm's total stake to 15.95 million shares...
Adage Capital, Point72 Raise Stakes In These Pharmaceutical Companies
Phill Gross and Robert Atchinson of Adage Capital Partners remain bullish on Cynapsus Therapeutics Inc (NASDAQ:CYNA) according to their latest 13G filing with the SEC.
Steve Cohen, Peter Kolchinsky Disclose New Stakes In Micro-cap Pharmaceutical Stocks
Steve Cohen’s Point72 Asset Management has initiated a new position in Inotek Pharmaceuticals Corporation (NASDAQ:ITEK).
- First
- << Previous
- 341 - 350
- Next >>